Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Lansoprazole
Takeda
Functional Dyspepsia
1 trial -
Lansoprazole
Takeda
Gastroesophageal Reflux
1 trial -
Lansoprazole (Prevacid)
Takeda
Zollinger-Ellison Syndrome
1 trial -
Lantus 100 units/ml solution for injection in a cartridge, Lantus 100 units/ml solution for injection in a vial, Toujeo 300 units/ml DoubleStar, solution for injection in a pre-filled pen, Awiqli 700 units/mL solution for injection in pre-filled pen, Levemir FlexPen 100 units/ml solution for injection in pre-filled pen., Toujeo 300 units/ml DoubleStar, solution for injection in a pre-filled pen, Tresiba 200 units/mL FlexTouch solution for injection in pre-filled pen, Tresiba 100 units/mL FlexTouch solution
NovoThirteen
Type 2 diabetes
1 trial -
Lecanemab 10 mg/kg
The First People's Hospital of Lianyungang
Alzheimer s Disease
1 trial -
Ledipasvir 90mg/Sofosbuvir 400 mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
Lesinurad
IRONWOOD PHARMACEUTICALS INC
Gout
1 trial -
Leucovorin calcium
Ultragenyx UK Limited
Toxoplasmosis
1 trial -
Leuprorelin
Takeda
Central Precocious Puberty
1 trial -
Leuprorelin Acetate Depot 3M
Takeda
Central Precocious Puberty
1 trial -
Levobupivacaine
United Therapeutics Europe Ltd
Arthroplasty, Replacement, Knee
1 trial -
Levobupivacaína Normon 5 mg/ml solución inyectable y para perfusión EFG, Inibsacain 5 mg/ml + 0,005 mg/ml solución inyectable en cartucho
The George Institute
Hip fracture
1 trial -
Levocarnitine Injection
The First People's Hospital of Lianyungang
Renal Dialysis
1 trial -
Levofloxacin
Hospital Authority, Hong Kong
Urinary Tract Infection
1 trial -
Levosimendan
COLLEGIUM PHARMACEUTICAL, INC
Systolic Heart Failure
1 trial -
Levosimendan Kalceks 2,5 mg/ml concentraat voor oplossing voor infusie, Soluvit N poeder voor oplossing voor intraveneuze infusie
Disc Medicine
Failure to wean from invasive ventilation.
1 trial -
Levothyroxine
United Therapeutics Europe Ltd
Hypothyroidism
1 trial -
Levothyroxine
The First People's Hospital of Lianyungang
Heart Failure
1 trial -
Linaclotide
IRONWOOD PHARMACEUTICALS INC
Irritable Bowel Syndrome Characterized by Constipation
2 trials -
Linaclotide
IRONWOOD PHARMACEUTICALS INC
Irritable Bowel Syndrome With Constipation
3 trials -
Liposomal Bupivacaine
Pacira Ireland Limited
Male Infertility
1 trial -
Lithium Carbonate 250 MG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sleep Deprivation
1 trial -
Live Combined Bifidobacterium and Lactobacillus
The First People's Hospital of Lianyungang
Functional Constipation
1 trial -
Livmarli 9.5 mg/mL oral solution
Lacuna Pharma Pty Ltd
Progressive Familial Intrahepatic Cholestasis, Alagille syndrome
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources